CXCL13 is enriched in fibroblasts and CD8 + T cells in breast cancer, CD8 + Tex and CD4 + Tconv cells in colon cancer, and plasma in pancreatic cancer (Figure 16D,E,F). This evidence concerns the gene CD4 and malignant colon neoplasm.